Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
Pediatr Infect Dis J
    July 2023
  1. CHABALA C, Turkova A, Kapasa M, LeBeau K, et al
    Inadequate Lopinavir Concentrations With Modified 8-hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV.
    Pediatr Infect Dis J. 2023 Jul 20. doi: 10.1097/INF.0000000000004047.
    >> Share

  2. GILL MM, Herrera N, Guilaze R, Mussa A, et al
    Virologic Outcomes and ARV Switch Profiles 2 Years After National Rollout of Dolutegravir to Children Less Than 15 Years in Southern Mozambique.
    Pediatr Infect Dis J. 2023 Jul 6. doi: 10.1097/INF.0000000000004037.
    >> Share

    June 2023
  3. CHETTY T, Pillay A, Balakrishna Y, Reddy T, et al
    Healthcare-Associated Infections Drive Antimicrobial Prescribing in Pediatric Departments at Three Academic Hospitals in South Africa.
    Pediatr Infect Dis J. 2023 Jun 23. doi: 10.1097/INF.0000000000003954.
    >> Share

  4. DUNLOP JL, Tait CL, Njuguna C, Frost KM, et al
    A Single Question on Maternal HIV Status Can Improve Identification of Children Living With HIV in South Africa.
    Pediatr Infect Dis J. 2023 Jun 21. doi: 10.1097/INF.0000000000004007.
    >> Share

    May 2023
  5. WOLF HT, Amole C, Singh V, Penazzato M, et al
    One Step Closer to Ending AIDS in Children.
    Pediatr Infect Dis J. 2023 May 17. doi: 10.1097/INF.0000000000003964.
    >> Share

  6. NAKIDDU NJ, Bakeera-Kitaka S, Musoke P
    Prevalence and Factors Associated With Delayed Puberty Among Adolescents on Boosted Protease Inhibitor-based Second-line Antiretroviral Therapy: A Cross-sectional Study at a Pediatric Infectious Diseases Clinic in Uganda.
    Pediatr Infect Dis J. 2023;42:407-411.
    >> Share

    April 2023
  7. MCKENZIE C, Schaaf HS, Croucamp R, Palmer M, et al
    Recurrent Tuberculosis Treatment Episodes in Children Presenting With Presumptive Pulmonary Tuberculosis in Cape Town, South Africa.
    Pediatr Infect Dis J. 2023 Apr 19. doi: 10.1097/INF.0000000000003922.
    >> Share

    March 2023
  8. DENOEUD-NDAM L, Stecker C, Andifasi P, Mushavi A, et al
    Implementation and Uptake of Raltegravir Granules in Newborns Diagnosed With HIV Through Birth Testing in Maternity Settings in Zimbabwe During the COVID-19 Pandemic.
    Pediatr Infect Dis J. 2023 Mar 20. doi: 10.1097/INF.0000000000003906.
    >> Share

  9. ROSE PC, De la Rey Nel E, Cotton MF, Otwombe K, et al
    Decreased Hepatic Steatosis in South African Adolescents With Perinatal HIV Switching to Dolutegravir-containing Regimens.
    Pediatr Infect Dis J. 2023 Mar 14. doi: 10.1097/INF.0000000000003904.
    >> Share

    February 2023
  10. OLBRICH L, Nliwasa M, Sabi I, Ntinginya NE, et al
    Rapid and Accurate Diagnosis of Pediatric Tuberculosis Disease (RaPaed-TB): A Diagnostic Accuracy Study for Pediatric Tuberculosis.
    Pediatr Infect Dis J. 2023 Feb 16:e003853. doi: 10.1097/INF.0000000000003853.
    >> Share

  11. SUTCLIFFE CG, Moyo N, Hamahuwa M, Mutanga JN, et al
    The Evolving Pediatric HIV Epidemic in Rural Southern Zambia: The Beneficial Impact of Advances in Prevention and Treatment at a District Hospital From 2007 to 2019.
    Pediatr Infect Dis J. 2023 Feb 15. doi: 10.1097/INF.0000000000003873.
    >> Share

  12. BACHA JM, Dlamini S, Anabwani F, Gwimile J, et al
    Realizing the Promise of Dolutegravir in Effectively Treating Children and Adolescents Living With HIV in Real-world Settings in 6 Countries in Eastern and Southern Africa.
    Pediatr Infect Dis J. 2023 Feb 14. doi: 10.1097/INF.0000000000003878.
    >> Share

  13. DODI I, Romanini E, Veronese P, Cangelosi AM, et al
    Highly Active Antiretroviral Therapy in an Extremely Low Birth Weight Newborn With in Utero Transmission of HIV.
    Pediatr Infect Dis J. 2023 Feb 8. doi: 10.1097/INF.0000000000003857.
    >> Share

  14. GROSS J, Medley A, Rivadeneira E, Battey K, et al
    Considerations to Improve Pediatric HIV Testing and Close the Treatment Gap in 16 African Countries.
    Pediatr Infect Dis J. 2023;42:110-118.
    >> Share

    January 2023
  15. TOURE F, Etheredge GD, Brennan C, Parris K, et al
    Retention and Predictors of Attrition Among HIV-infected Children on Antiretroviral Therapy in Cote d'Ivoire Between 2012 and 2016.
    Pediatr Infect Dis J. 2023 Jan 23. doi: 10.1097/INF.0000000000003839.
    >> Share

  16. HRAPCAK S, Pals S, Itoh M, Peters N, et al
    HIV Viral Load Scale-up Among Children and Adolescents: Trends in Viral Load Suppression, Sample Type and Processing in 7 PEPFAR Countries, 2015-2018.
    Pediatr Infect Dis J. 2023 Jan 18. doi: 10.1097/INF.0000000000003824.
    >> Share

    November 2022
  17. VAN WARMERDAM J, Campigotto A, Bitnun A, MacDougall G, et al
    Invasive Pneumococcal Disease in High-Risk Children: A 10-Year Retrospective Study.
    Pediatr Infect Dis J. 2022 Nov 18. doi: 10.1097/INF.0000000000003748.
    >> Share

    October 2022
  18. WANG L, Kourtis AP, Wiener J, Chen L, et al
    Impact of Tenofovir Disoproxil Fumarate Use During Pregnancy on Maternal Bone Mineral Density.
    Pediatr Infect Dis J. 2022 Oct 11. pii: 00006454-990000000-00212.
    >> Share

    September 2022
  19. KADAMBARI S, Evans C, Lyall H
    Congenital Infections: Priorities and Possibilities for Resource-limited Settings.
    Pediatr Infect Dis J. 2022 Sep 12. pii: 00006454-990000000-00191.
    >> Share

  20. DESAI N, Jenkins CA, Zanoni B, Nmoh A, et al
    High Rates of Viral Suppression and Care Retention Among Youth Born Outside of the United States with Perinatally Acquired HIV.
    Pediatr Infect Dis J. 2022 Sep 8. pii: 00006454-990000000-00187.
    >> Share

  21. DUVENHAGE J, Draper HR, Garcia-Prats AJ, Winckler J, et al
    Hepatocellular Injury in Children Treated for Rifampicin-resistant Tuberculosis: Incidence, Etiology and Outcome.
    Pediatr Infect Dis J. 2022 Sep 6. pii: 00006454-990000000-00179.
    >> Share

    August 2022
  22. LIYANAGE M, Nikanjam M, McFadyen L, Vourvahis M, et al
    Maraviroc Population Pharmacokinetics Within the First 6 Weeks of Life.
    Pediatr Infect Dis J. 2022 Aug 9. pii: 00006454-990000000-00156.
    >> Share

    July 2022
  23. STEEGEN K, Levin L, Evans D, Technau KG, et al
    Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment.
    Pediatr Infect Dis J. 2022 Jul 20. pii: 00006454-990000000-00138.
    >> Share

  24. BERZOSA SANCHEZ A, Epalza C, Navarro ML, Alcolea S, et al
    SARS-CoV-2 Infection in Children and Adolescents Living With HIV in Madrid.
    Pediatr Infect Dis J. 2022 Jul 6. pii: 00006454-990000000-00119.
    >> Share

    May 2022
  25. KIRMSE B, Hobbs C, Aaron L, Montepiedra G, et al
    Acylcarnitines and Genetic Variation in Fat Oxidation Genes in HIV-infected, Antiretroviral-treated Children With and Without Myopathy.
    Pediatr Infect Dis J. 2022 May 25. pii: 00006454-990000000-00083.
    >> Share

  26. JIANG M, Wang HM, Zhou GL, Chen YS, et al
    Invasive Salmonella Infections Among Children in Shenzhen, China: A Five-year Retrospective Review.
    Pediatr Infect Dis J. 2022 May 23. pii: 00006454-990000000-00079.
    >> Share

    April 2022
  27. HOFF CALEGARI L, Friedrich L, Rech Astolfi V, Kerber JM, et al
    The Impact of Maternal Syphilis and Associated Factors on HIV Vertical Transmission.
    Pediatr Infect Dis J. 2022 Apr 18. pii: 00006454-990000000-00049.
    >> Share

    February 2022
  28. BOETTIGER DC, An VT, Lumbiganon P, Wittawatmongkol O, et al
    Severe Recurrent Bacterial Pneumonia Among Children Living With HIV.
    Pediatr Infect Dis J. 2022 Feb 18. pii: 00006454-900000000-95532.
    >> Share

  29. DOLLFUS C, Le Chenadec J, Mandelbrot L, Tubiana R, et al
    Improved Hematologic Outcomes in HIV1-exposed Infants Receiving Nevirapine Compared With Zidovudine for Postnatal Prophylaxis in a High Resource Setting.
    Pediatr Infect Dis J. 2022 Feb 7. pii: 00006454-900000000-95545.
    >> Share

  30. JACOBS TG, van Aerde KJ, Colbers A, Burger DM, et al
    Raltegravir-based Postnatal HIV Prophylaxis Therapy in a Neonate After in Utero Dolutegravir Exposure.
    Pediatr Infect Dis J. 2022;41:131-132.
    >> Share

    January 2022
  31. MALIK F, Malyuta R, Volokha A, Bailey H, et al
    Hepatitis C Virus Treatment Response to Direct-acting Antivirals Among Adolescents With HIV/HCV Coinfection: Real-world Data From Ukraine.
    Pediatr Infect Dis J. 2022 Jan 20. pii: 00006454-900000000-95560.
    >> Share

  32. MORREALE A, Dotta L, Vairo D, Bazzana T, et al
    When a Nontuberculous Mycobacterial Infection Reveals an Error of Immunity: A Single Center's Experience.
    Pediatr Infect Dis J. 2022 Jan 17. pii: 00006454-900000000-95554.
    >> Share

  33. GARCIA-BOYANO M, Chavez-Solorzano N, Layana-Coronel M, Soffe-Pazmino J, et al
    Determinants of Disclosure, Adherence and Viral Suppression in Children and Adolescents Living With HIV in Ecuador: A Cross-Sectional Study.
    Pediatr Infect Dis J. 2022 Jan 11. pii: 00006454-900000000-95566.
    >> Share

    December 2021
  34. KHAMADI S, Lwembe R, Maosa N, Maloba M, et al
    HIV Drug Resistance in Kenyan Infants Diagnosed With HIV and Their Mothers.
    Pediatr Infect Dis J. 2021 Dec 21. pii: 00006454-900000000-95584.
    >> Share

  35. ILLAN RAMOS M, Soto Sanchez B, Mazariegos Orellana D, Prieto Tato LM, et al
    Safety and Experience With Combined Antiretroviral Prophylaxis in Newborn at High-risk of Perinatal HIV Infection, in a Cohort of Mother Living With HIV-infant Pairs.
    Pediatr Infect Dis J. 2021;40:1096-1100.
    >> Share

    November 2021
  36. MUHAIRWE JA, Brown JA, Motaboli L, Nsakala BL, et al
    The Suboptimal Pediatric HIV Viral Load Cascade: Multidistrict Cohort Study Among Children Taking Antiretroviral Therapy in Lesotho, Southern Africa.
    Pediatr Infect Dis J. 2021 Nov 30. pii: 00006454-900000000-95608.
    >> Share

  37. LOERINC L, Scheel A, Jordan-Thompson S, Gillespie S, et al
    Incidence, Reinfection, and Discrepancy Between Sexual Practice and Anatomic Site Positivity of Sexually Transmitted Infections in Youth With HIV.
    Pediatr Infect Dis J. 2021 Nov 9. pii: 00006454-900000000-95630.
    >> Share

    October 2021
  38. LI SNJ, Albert A, Piske M, Janssen PA, et al
    Higher Hospitalization Rates in Children Born HIV-exposed Uninfected in British Columbia, Canada, Between 1990 and 2012.
    Pediatr Infect Dis J. 2021 Oct 26. pii: 00006454-900000000-95644.
    >> Share

  39. MILLS A, Myers L, Raudenbush C, Vossen DA, et al
    A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use.
    Pediatr Infect Dis J. 2021 Oct 19. pii: 00006454-900000000-95652.
    >> Share

  40. SINGH RP, Adkison KK, Baker M, Parasrampuria R, et al
    Development of Dolutegravir Single-entity and Fixed-dose Combination Formulations for Children.
    Pediatr Infect Dis J. 2021 Oct 12. pii: 00006454-900000000-95623.
    >> Share

    September 2021
  41. PEREIRA NMD, Heath PT, Doerholt K, Almario-Hernandez AF, et al
    SARS-CoV-2 Infection in an Adolescent With X-linked Agammaglobulinemia.
    Pediatr Infect Dis J. 2021 Sep 28. pii: 00006454-900000000-95663.
    >> Share

  42. MILLER C, Daugherty R, McCulloch M, Stephens I, et al
    Immune Reconstitution Inflammatory Syndrome Complicating Cryptococcal Meningitis in a Pediatric Heart Transplant Patient.
    Pediatr Infect Dis J. 2021 Sep 7. pii: 00006454-900000000-95687.
    >> Share

  43. WEYLAND C, Mirani G, Gillespie SL, Paul ME, et al
    A Case of in utero Transmission of Drug-resistant HIV in the United States.
    Pediatr Infect Dis J. 2021 Sep 7. pii: 00006454-900000000-95685.
    >> Share

  44. HRAPCAK S, Bekele A, Ahmed J, Ayalew J, et al
    Finding Children Living With HIV in Low-prevalence Countries: HIV Prevalence and Testing Yield From 5 Entry Points in Ethiopia.
    Pediatr Infect Dis J. 2021 Sep 7. pii: 00006454-900000000-95684.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016